Aim Rectal cancer patients undergoing neoadjuvant chemoradiotherapy (NACRT) experience physical deterioration and reductions in their quality of life. This feasibility study assessed prehabilitation (a walking intervention) before, during and after NACRT to inform a definitive multi-centred randomized clinical trial (REx trial).
Introduction
Earlier diagnosis and advances in surgery and chemoradiotherapy are improving long-term survival for rectal cancer [1] . Long-course neoadjuvant chemoradiotherapy (NACRT) can downstage locally advanced rectal cancer optimizing the chance of an R0 resection or, in the event of a complete response, removing the immediate need for major pelvic surgery [2] [3] [4] [5] . However, 5-6 weeks of NACRT can be challenging. About 22% of patients experience severe acute side effects such as haematological toxicity, sepsis, enteritis, radiological dermatitis and cardiotoxicity [6] . These can lead to deteriorations in physical and social functioning, accompanied by increased levels of incontinence, embarrassment and fatigue that can persist for many months or years [7] [8] [9] . Whilst many patients have low levels of physical fitness prior to starting neoadjuvant treatment, NACRT has the potential to make a patient physically vulnerable prior to undergoing surgery [10] .
Patients approaching major surgery with poorer physical fitness (aerobic capacity, muscular strength, endurance, flexibility and body composition) are at greater risk of postoperative morbidity and mortality [11] [12] [13] [14] [15] . Prehabilitation, an intervention to enhance the functional capacity of the individual to enable him or her to withstand a stressful event, has become an evolving area of interest. Published studies that have assessed both the feasibility of such an intervention and any influences on postoperative outcomes have varied in methodology and patient population [16] [17] [18] . However, a recent systematic review of nine studies (435 patients) in patients undergoing major abdominal surgery concluded that prehabilitation decreased the incidence of postoperative major complications (OR 0.59, 95% CI 0.38-0.91), especially pulmonary [19] .
For rectal cancer patients, current standard care creates a minimum timeframe of 2 months from completion of NACRT to potential surgery and this provides a window for prehabilitation, which is unavailable to patients going straight to surgery given the current local target of 31 days [20] .
One non-randomized study of 39 patients reported a reduction in physical fitness (using cardiopulmonary exercise testing) on completion of long-course NACRT. Only the intervention group who went on to receive three supervised aerobic sessions per week for 6 weeks, compared to the standard care control group, returned to baseline fitness levels, raising the possibility that prehabilitation could minimize the anticipated NACRT decline [17] .
A Canadian study anticipated this decline and recruited 18 patients to undergo prehabilitation during and after NACRT [21] . This consisted of a supervised aerobic exercise programme (three sessions per week during NACRT) followed by an unsupervised programme (target of 150 min plus per week for 6-8 weeks after NACRT). There were no serious adverse events with the authors concluding that the next step should be a feasibility study.
The aim of our study was to assess the feasibility of performing a physical activity intervention prior to, during and after NACRT in patients with rectal cancer. The primary aim was to assess the feasibility of delivering such an intervention with indicative outcomes also recorded to inform the design of a definitive randomized controlled trial (RCT).
Method
The study ran from August 2014 to March 2016 (20 months). Patients (age > 18 years) presenting with a new diagnosis of rectal cancer in one National Health Service trust (Greater Glasgow and Clyde) between August 2014 and March 2015 were considered eligible for the REx trial if they satisfied the following: histology confirmed adenocarcinoma; preoperative MRI staging determined the tumour was margin-threatening and/or anatomically low in the pelvis; CT of chest, abdomen and pelvis showed no evidence of metastatic disease; and finally the multidisciplinary team recommended long-course NACRT followed by potentially curative surgery. Patients were excluded for the following: metastatic disease; their mobility prevented them from performing a walking intervention; they were already achieving their recommended government guidelines for physical activity per week (using the Scottish Physical Activity Screening Questionnaire) [22]; or they had any physical, mental or psychological impairment that prevented signed informed consent.
The trial was approved by the West of Scotland Research Ethics Service (14/WS/0079) and registered with ISRCTN (www.isrctn.com; 62859294; 17 March 2014). The trial was reported using the CONSORT 2010 Guidelines [23] . This study was funded by the Chief Scientist Office (CZH/4/986) www.cso.scot.nhs.uk.
Trial design
This was a two-arm randomized controlled feasibility study. Potentially eligible patients were screened by the trial team and were then approached by the patient's colorectal cancer nurse specialist at the time of one of their surgical or oncological consultations. The study coordinator then followed up interested participants by telephone and scheduled for consent and baseline testing. Informed written consent was taken by participating colorectal surgeons.
Primary outcomes
The primary outcomes were feasibility and acceptability of the research procedures, as assessed by eligibility and recruitment rates (including reasons for non-participation), participant acceptability of randomization, data collection and physical intervention and rates of retention and adherence to the physical activity intervention. Acceptability of randomization was estimated from the percentage of participants attending baseline measurements who gave informed consent to take part in the feasibility trial. The number of telephone calls planned and subsequently received by each participant in the intervention group during the physical activity intervention measured adherence to the intervention. Trial satisfaction was assessed by asking each participant how much they were in agreement with the following four questions using a Likert scale from 1 (not at all in agreement) to 5 (very much in agreement): how satisfied were you with the REx trial?, how convenient did you find coming up to the hospital for trial appointments?, how easy did you find the pedometer to use (intervention group only)? and how likely would you be to recommend the REx trial to other people with rectal cancer?
At the weekly telephone call to each participant in the intervention group, the research assistant was asked to grade the fidelity of the intervention using a Likert score (1 poor to 5 high). Any protocol deviations were recorded.
Secondary outcomes
The primary efficacy outcome was median step count per day. Other secondary outcomes included physical, psychological and perioperative variables. All outcomes were assessed at baseline testing pre-intervention (baseline test 1 prior to undergoing NACRT) and repeated post-intervention (1-2 weeks pre-surgery, test 2) with perioperative variables collected within the first few weeks after surgery (Fig. 1) .
In addition to demographic and clinico-pathological characteristics, the following physical measurements were taken: weight, height, hip and waist circumference, sitto-stand test and 6 min walking test (6MWT). Waist circumference was measured with a measuring tape, with participants in the standing position and the tape positioned midway between the lateral lower rib margin and the iliac crest [24] . If these landmarks could not be identified, the measurement was taken at the level of the umbilicus. Hip measurement was taken around the widest portion of the buttocks. Both measurements were taken twice. Weight and height allowed calculation of body mass index: weight (kg)/height (m 2 ). The sit-tostand test was administered over 30 s, during which each participant crossed their arms and moved from sitting to a full standing position (body straight). This was repeated as many times as possible during the timeframe to allow assessment of functional lower extremity strength, which has been validated in many groups, especially older adults [25] . The 6MWT is an objective measurement of functional exercise capacity that, in addition to being safe in a variety of populations, has shown good correlation with the 12 min walk test and the cycle ergometer and treadmill exercise tests [26, 27] . A flat, indoor surface was selected with markers placed 12.5 m apart. Participants were then requested to walk as far as they could in 6 min with the final distance (m) being recorded. At the end of the baseline testing each participant was instructed on how to use the accelerometer to record data for 3-5 days. The activPAL (activPAL3; PAL Technologies, Glasgow, UK) is a small (53 9 35 9 7 mm) lightweight (15 g) triaxial accelerometer that was gently placed over their anterior thigh with an adhesive dressing, allowing anonymous data collection. Data were uploaded using the activPAL software for a sedentary time, active time and average steps walked per day. Mean daily step counts were categorized as follows: sedentary (< 5000 steps/day); mildly active (5000-6999); moderately active (7000-10 999); and very active (≥ 11 000 steps) [28] . Each participant repeated this after test 2.
Questionnaires
Each participant completed the following at pre-NACRT and post-NACRT testing: Becks Depression Inventory (BDI-II), Functional Assessment of Cancer TherapyColorectal (FACT-C), Positive and Negative Affect Schedule (PANAS), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) CR29 and C30. The existence and severity of symptoms of depression were measured using the BDI-II [29] . A total of 21 items are summed to give a single point score: 0-13 normal or minimal depression; 14-19 mild; 20-28 moderate and 29-63 severe. Colorectal cancer specific quality of life was measured using the FACT-C. This includes 27 items from the FACT-General (FACT-G) and adds in 11 items specific to colorectal cancer, with a higher score indicating a better quality of life and a change of at least 2 being stated as clinically relevant [30] . The PANAS is a 20-item self-reported measure of two scales, one to measure positive affect (where higher scores represent higher levels of positive affect) and the other negative affect (where lower levels represent lower levels of negative affect) [31] . EORTC QLQ C30 is the widely used and validated quality of life questionnaire for all cancer patients by the European Organization for Research and Treatment of Cancer. It comprises nine multi-item scales and six single item scales. EORTC QLQ C29 specifically assesses quality of life in colorectal cancer patients and was administered alongside the C30 [32] .
Randomization
Participants were randomized 1:1 to either the physical intervention or control group (standard care) using block size 4 and no stratification. Randomization was performed using an interactive voice response telephone system provided by the Robertson Centre for Biostatistics. After each participant had completed pre-NACRT testing, the research assistant received the group allocation via the interactive voice response system and provided it to the participant. The testers were blinded to the group allocation throughout as were their surgeons, nurse specialists and hospital staff involved in their care.
Physical activity intervention
Participants randomized to the intervention group had an initial face-to-face consultation with the study coordinator who had been trained in the application of two behavioural theoretical frameworks: self-regulatory theory (providing techniques to improve impulse control allowing walking targets to be reached) and the health action process approach (replacing behaviours that compromise health with those that enhance health) [33, 34] .
The walking programme started prior to NACRT and was a minimum of 13 weeks' duration: 5 weeks of NACRT followed by a minimal time interval of 8 weeks prior to surgery determined by individual surgeons' usual practice. The programme was based on targeted stepping counts: the first 8 weeks consisted of graduated goals calculated from the baseline stepping count (identified from the pre-NACRT accelerometer result) with that behaviour then maintained or increased over the remaining weeks up to surgery. Each participant was given a weekly walking diary (targets and motivational material included) and the use of the pedometer was explained. Participants then received follow-up telephone calls (weeks 1, 3, 5, 7, 9, 12, 16) where new stepping targets were set, motivational techniques were applied and any issues were discussed. All participants were asked to engage a support person (e.g. spouse) to assist in their adherence with the programme.
The target was for the participants to increase their average daily step count by 3000 accumulated above their baseline value which is a protocol that has been used successfully before by this research team and other researchers [28, [35] [36] [37] [38] . This is based on the assumption that an adult walking at a moderate pace produces 100 steps/min. Therefore an increase of 3000 steps in 1 day is equal to 30 min extra activity that, if performed on 5 days of the week, would correspond to approximately 150 min of moderate physical activity over the course of the week which is the recommended physical activity level for adults in Scotland [22] .
Below is an example. Weeks 1-2: extra 1500 steps on at least 3 days a week.
Weeks 3-4: extra 1500 steps on at least 5 days a week.
Weeks 5-6: extra 3000 steps on at least 3 days a week. Weeks 7-8: extra 3000 steps on at least 5 days a week. Weeks 9-17: maintenance of weeks 7-8 or individually increased.
Control group
The control group received standard care with no contact from the trial team except at the two test sessions. When informed of their allocation to the control group, they were told to maintain their normal level of physical activity. They were offered a voluntary exercise counselling session and information pack from the trial team after their surgery and on completion of the trial.
Neoadjuvant chemoradiotherapy
Radiotherapy dose was standardized at 4500 cGY in 25 fractions on weekdays only accompanied by oral capecitabine 900 mg/m 2 twice daily on the same day or fluorouracil 350 mg/m 2 intravenously on weeks 1 and 5.
Perioperative outcome variables
For each participant who underwent surgery the following were recorded: length of hospital stay; surgery type; number of postoperative complications [39] . In addition, the pathology of the resected specimen was recorded.
Sample size
This was a phase 1 feasibility study to test practical aspects of the study design and to help inform the calculation of effect sizes for a subsequent definitive fully powered RCT. From the West of Scotland Colorectal Cancer Managed Clinical Network 2013-2014 data, approximately 100 patients per year were deemed eligible for inclusion in this study. We estimated that we could recruit 80 patients during the planned 18-month trial recruitment period (40 intervention and 40 control), and this would provide sufficient data to determine feasibility.
Statistical analysis
The main aim was to assess the feasibility of intervention delivery to inform the design of a main trial; thus the indicative outcomes are underpowered for statistical interpretation. Descriptive tables to summarize the feasibility measures by each group were performed, with means and standard deviations or medians and interquartile ranges calculated for continuous variables, depending on whether or not they were normally distributed, and counts and percentages for categorical variables. Wilcoxon tests were used to compare satisfaction scores between study groups. The most relevant physical outcome (measured average daily step count) was compared between groups using a linear regression model fitted to change from baseline, adjusting for the number of steps per day at baseline, age and gender, and presented as a mean estimate of the group difference with a corresponding 95% confidence interval. Study group comparisons of change from baseline in other physical and psychological outcome measures were carried out using two-sample t tests and within-group comparisons for all measures of within-patient change from baseline to follow-up using paired t tests, and both were presented as mean estimates and corresponding 95% confidence intervals. The EORTC CR29 embarrassment measure was compared from baseline to follow-up within groups using multinomial tests, and change from baseline between groups was assessed using a Fisher's exact test.
All statistical analysis was undertaken using R for Windows (version 3.4.1, The R Foundation for Statistical Computing, Vienna, Austria) or the SAS application software (version 9.3, SAS Institute Inc., Cary, North Carolina, USA).
Results

Feasibility
During the trial's timeframe, a total of 296 patients were diagnosed with rectal cancer. Seventy-eight patients were put forward by their multidisciplinary team for NACRT (26%) (Fig. 1) . Screening showed that all 78 patients were eligible for the trial and they were approached, with 48 patients attending for baseline testing and consent (recruitment rate 62%). The main reasons given for not participating were 'too much going on' and 'overwhelmed by the diagnosis'. No patients were excluded for achieving the recommended government guidelines for physical activity per week.
All participants completed baseline testing and randomization with 24 participants randomized to the intervention group (Table 1) . A median walking intervention duration of 14 weeks (interquartile range 13-17) was completed with 80% of planned telephone calls to the intervention group being achieved and 75% completing the intervention (Table 1) .
Overall, a total of eight participants did not complete the study: six from the intervention group and two controls (retention rate 83%). Two of the intervention group withdrew prior to starting the intervention and, of the remaining six drop-outs, four were for medical reasons (Fig. 1 ). There were no serious adverse events reported and no treatment pathways were modified as a consequence of trial participation.
At the end of the trial, participants from both groups reported high levels of satisfaction with the trial and would recommend prehabilitation to other patients (Table 2 ). Intervention fidelity assessments found an overall mean score of 4.0 (range 1-5) for the telephone-guided intervention. Deviations from the protocol included several attempts by the research assistant to contact participants on their telephone and modifying the weekly target step count depending on the participant's weekly clinical status.
Baseline participant characteristics
Participants had a mean age of 65.9 years (range 33.7-82.6) and were predominately men (65%) and of white ethnicity (96%) and all were educated to at least completion of secondary education. 38% of participants were from the two most deprived socioeconomic groups. Comorbidities were present in 57%, with hypertension (present in 59% of those with comorbidities) and arthritis (30%) most commonly recorded (Table 3) . Most (60%) participants currently or had previously smoked, 88% reported current alcohol consumption, 71% were overweight (body mass index ≥ 25) with 19% obese (≥ 30). The majority of participants (90%) stated they could complete a flight of stairs without stopping; however, on average they were only active for 1.6 h a day (6.6% of their week). The mean number of steps per day of all participants was 7392 (range 1151-17 422) with 54% classified as sedentary or only slightly active (Table 4) . In relation to psychological testing, participants did not report being depressed [BDI mean score 7.2 (6.6)] and had a reasonable quality of life although fatigue and embarrassment were commonly reported (Table 4) .
Follow-up testing
Results from follow-up testing are displayed in Table 5 . For the primary efficacy outcome (mean of the median daily step count), both groups recorded a reduction in step count: the intervention group dropped by a mean of 1105 steps (15% reduction from baseline), whilst the control group reported a greater drop of 1853 steps (24% reduction from baseline) (Fig. 2) . This difference between groups in change from baseline of 785 (95% CI À1194, 2765) was not significant (adjusted for baseline median daily step count, age and gender).
A higher percentage of the intervention group achieved step count improvements at 12 weeks (23.5% vs 15.8%). The intervention group also documented a non-significant mean increase of 13.7 m in their 6MWT scores, while the control group showed a mean 54.8 m reduction, which resulted in a non-significant between-group difference of 68.5 m (95% CI À27.2, 164.2).
There were no statistically significant changes within and between groups in relation to any of the psychological questionnaires. Table 6 describes the clinico-pathological factors in all participants finding the majority successfully completed NACRT (98%). Most participants (36 out of 40) underwent surgery with 33 being of curative intent, two local excisions due to poor fitness and one had a defunctioning stoma performed. Of the four patients who did not undergo surgery, three had progressive disease on their post-NACRT imaging with the other participant having a complete response to NACRT on follow-up imaging. The majority of surgery was performed electively (97%), by an open approach (72%) with a permanent end-colostomy formed in 61%. All grades of postoperative complications were recorded in 67% of cases with T3 N0 being the most commonly recorded pathological TNM staging. The tumour was completely resected (R0) in 86% of surgical procedures.
Perioperative outcome variables
Discussion
This is the first RCT to assess the feasibility of performing a walking intervention (prehabilitation) in patients with rectal cancer undergoing NACRT and with good recruitment, good retention and high participant satisfaction with trial procedures, all without compromise to the planned treatment pathway; these results support proceeding to a future definitive multicentred RCT.
The demographics of the participants show that performing a walking intervention is feasible in groups that (2) 23 (1) 23 ( can be considered challenging in both recruitment and adherence; older adults (40% were over 70), those with high levels of socioeconomic deprivation (38%) and in patients with comorbidities, including potentially activity limiting conditions such as arthritis. Furthermore many participants reported smoking, alcohol consumption and being overweight, in addition to high levels of sedentary behaviour. Many of these factors either by themselves or in combination are traditionally associated with a patient potentially being labelled as 'high risk' for treatment morbidity and mortality, a statement that is supported by the reported complication rate of 67% in this study. Indeed, previous work has found that such patients account for 85% of perioperative complications making them a key area to target. Despite this many prehabilitation protocols have excluded such patients [40] . One recently published RCT supports our findings by recruiting only high-risk patients going straight to major abdominal surgery. This study defined 'high risk' as age > 70 years and/or American Society of Anesthesiologists score III/ IV [41] . With a mean intervention time of 6 weeks to perform a multimodal prehabilitation programme (lifestyle counselling, nutrition assessment, iron therapy as appropriate accompanied by a physical activity programme), the authors reported that 54 out of 73 completed the intervention (73%) without any serious adverse events. In addition, these authors found a significant reduction in postoperative complications in the prehabilitation group compared to the usual care controls (31% vs 62%; P = 0.001). These results suggest that not only is prehabilitation feasible in high-risk patients but that their risk of complications can be modified.
The reduction in daily step counts of the participants confirms the previously reported negative effect that NACRT has on physical function in patients with rectal cancer [17] . Instituting a walking intervention is a proactive approach that may offset this decline and this is supported by the intervention group step count results from this study. However, a definitive trial needs to be powered for daily step count as its primary aim. Consideration must be given to delivering the optimal intervention that leads to the majority of participants in the intervention group achieving improved step counts. Individualized walking programmes have achieved success in older adults and over a shorter timeframe than in this study highlighting that there is no obvious reason why this patient population cannot achieve similar targets [35] [36] [37] 42] . Previous focus group work has mentioned the role of an exercise counsellor and how increased contact time (either by phone or face to face) could increase motivation and adherence to step targets. The role of motivational feedback also needs to be established as does the exact timing of treatment and testing after, including immediately upon completion of, NACRT. Specific strategies for dealing with patient reported fatigue need to be identified as this was a commonly reported barrier to patients undergoing prehabilitation. Consideration must also be given to educating all the health professionals who are involved in each patient's care to ensure that each participant is encouraged through their prehabilitation as they would be in all aspects of their treatment. This need for both healthcare professional and patient education is suggested by the two main reasons for refusal to participate in this study: 'too much going on' and 'overwhelmed by the diagnosis'.
Colorectal nurse specialists performed the initial approach and, at the outset, many were unaware or uncertain about the definition of prehabilitation and its potential role whilst undergoing treatment and its influence on long-term cancer related outcomes [43] [44] [45] . With education through face-to-face meetings and invited presentations at colorectal nurse meetings, in addition to their own patients' feedback, a culture change occurred. With nurse specialists documented as a preferred source of information for cancer patients, consideration to education for these specialists should be integrated in the future trial protocol [46] .
Limitations
The authors acknowledge limitations of this predominately single-centred feasibility study. Selection bias cannot be excluded because motivated patients are more likely to participate in prehabilitation. Furthermore, adherence to the walking intervention was self-reported and future work could consider including objective measures to monitor. In addition, the target of 80 patients was not achieved in this feasibility trial, primarily because the total number of rectal cancer patients suitable for NACRT had declined slightly from the previous year reflecting the natural diagnostic variation that could potentially be overcome with a large multicentred trial. In addition, with the interest in defining 'complete responders' to NACRT (no residual disease on post-NACRT imaging), it is entirely possible that in the coming years the number of patients being referred for NACRT will increase due to early rectal cancers (stages I or II) also being considered for NACRT.
Conclusion
This is the first RCT to assess the feasibility of performing a walking intervention (prehabilitation) in rectal cancer patients undergoing NACRT followed by potentially curative surgery. In addition to integrating around the multimodal and sometimes rapidly changing treatment pathway, prehabilitation was found to be feasible in a predominately inactive, comorbid, older adult population. With good recruitment, adherence and retention rates and the possibility of reducing the physical deterioration of NACRT, these results support the development of a fully powered trial to investigate the influence of prehabilitation on optimizing physical function and patient related outcomes.
